$25.59
Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
PCRX: Raising target price to $27.00
PCRX: Lowering target price to $26.00
Overview
52-week range
$19
$28
77% of range
Avg surprise (last 2)
+0.7%
Avg reaction (last 1)
-1.1%
0% positive
Latest IV / EM
60%
EM ±13.7% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.07 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.12 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.47 | $0.49 | -4.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.39 | $0.37 | +5.4% | — | -1.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-3.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.39 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.19 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.23 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.51 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | $0.27 | $0.47 | -42.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $36M | — | $34M | $41M | $34M | — | $39M | $44M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $7M | — | $6M | $8M | $2M | — | $-140M | $28M |
| Net income | $3M | — | $5M | $-5M | $5M | — | $-143M | $19M |
| EPS (diluted) | $0.07 | — | $0.12 | $-0.11 | $0.10 | — | $-3.11 | $0.39 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M |
| Inventory | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M |
| Total current assets | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M |
| Total assets | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B |
| Long-term debt | $368M | $372M | $377M | — | — | $384M | — | — |
| Total liabilities | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M |
| Total equity | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M |